Leucine, pyridoxine and resveratrol supplementation alter metabolic parameters in ponies with equine metabolic syndrome.
Authors: Norton Elaine M, Plumb Sydney, Shane Douglas, Smalley Lowell, McKendry Kent, Scharf Bob, Zemel Michael
Journal: Equine veterinary journal
Summary
# Editorial Summary: Leucine, Pyridoxine and Resveratrol for Equine Metabolic Syndrome Equine metabolic syndrome represents a significant management challenge, yet many commercially available supplements lack robust evidence supporting their metabolic claims. Norton and colleagues conducted a randomised, placebo-controlled trial across five farms to evaluate whether a supplement combining leucine, pyridoxine (vitamin B6) and resveratrol could meaningfully alter the metabolic profile in 38 ponies with confirmed EMS, using a rigorous protocol that measured insulin dynamics, lipid panels, adipokines and bodyweight over eight weeks. The supplement group demonstrated clinically relevant improvements: maximum post-oral sugar test insulin concentrations fell significantly between weeks one and four, with 50% of supplemented ponies achieving ≥40% reduction in peak insulin (averaging 36.6 μU/mL decrease) compared to minimal change in placebo animals; simultaneously, supplemented ponies lost an average of 8.1 kg over the trial period whilst controls gained 2.6 kg, with significantly more supplemented animals achieving ≥2% bodyweight loss. These results suggest the combination may support weight management and improve insulin sensitivity in EMS populations, though the authors acknowledge that multi-farm recruitment increased variability and may have obscured additional metabolic benefits. For practitioners, this evidence provides a preliminary evidence base for recommending this specific supplement formulation alongside established management strategies—particularly caloric restriction and exercise—though individual response variation warrants monitoring of insulin and weight parameters before and after implementation.
Read the full abstract on PubMed
Practical Takeaways
- •This supplement combination shows promise for managing metabolic dysfunction in EMS-affected ponies, with measurable improvements in insulin response and weight management over 60 days
- •Consider recommending this evidence-based supplementation approach as part of multimodal EMS management protocols, though results should be monitored individually on each farm
- •Weight loss achieved with supplementation (8.1 kg average) aligns with therapeutic goals for EMS; combine with appropriate diet and exercise management for optimal outcomes
Key Findings
- •Supplement group showed significant reduction in maximum insulin post-oral sugar test between timepoints 1-2 and 3-4
- •Supplement group lost average 8.1 kg bodyweight by day 60-61 while placebo group gained 2.6 kg (p=0.006)
- •More ponies in supplement group reduced maximum post-prandial insulin by ≥40% compared to placebo (p=0.01)
- •Leucine, pyridoxine and resveratrol combination may support weight loss and reduce insulin dysregulation in EMS